Stock market anomaly | Hutchison Healthcare (00013.HK) rises by more than 5% as it announces SACHI III clinical trial research data at ASCO 2025 annual meeting.

According to the Securities Times app, Hutchison Pharma (00013.HK) rose by more than 5%, as of the time of publication, it increased by 5.09% to HK $22.7, with a turnover of HK $65.0254 million.